Obesity Science Board Meeting Could Include Comparisons Of Marketed Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Discussion topics for the April 22 FDA meeting include cardiovascular endpoints and a revision of a 1996 draft guidance for weight control agents.